Skip to NavigationSkip to content

Business Services

Purespring Therapeutics to appoint Richard Francis as CEO

Published on: 11/01/21

Purespring Therapeutics, a kidney-focused AAV gene therapy company, has announced it will appoint Richard Francis as Chief Executive Officer from February this year.

Clinigen appoints Sam Herbert as Chief Operating Officer

Published on: 05/01/21

Clinigen, the global pharmaceutical and services company, has appointed Sam Herbert as Chief Operating Officer with immediate effect.

PureTech appoints George Farmer as Chief Financial Officer

Published on: 05/01/21

PureTech Health, a clinical-stage biotherapeutics company focused on highly differentiated medicines for devastating diseases, has appointed Dr George Farmer as its Chief Financial Officer.

As a key member of PureTech’s senior leadership team, Farmer will be responsible for all aspects of the company’s finances, including capital markets strategy and execution, strategic and financial planning, and financial reporting.

Novavax appoints Rick Crowley as Executive Vice President, Chief Operations Officer.

Published on: 22/12/20

Novavax, a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, has announced the appointment of Rick Crowley to the newly created position of Executive Vice President, Chief Operations Officer.

In this role, Crowley will have leadership responsibility for all operations, including Quality, Manufacturing, Supply Chain and Regulatory Affairs. He takes over manufacturing from Ben Machielse, who will continue with the company as an Executive Advisor to the Chief Executive Officer, supporting the development of the COVID-19 vaccine.

The importance of ethics and patient centricity in managed and early access programmes

Published on 21/12/20 at 05:30pm

Matt Fellows explores how early and managed access schemes are mutually beneficial to sponsors and patients alike, as well as how to ensure they can be as effective as possible in a rapidly changing world.

4BIO Capital appoints Akiko Iwasaki to its Scientific Advisory Board

Published on: 21/12/20

4BIO Capital, an international venture capital firm focused on advanced therapies addressing high unmet medical and social needs, has appointed Professor Akiko Iwasaki to its Scientific Advisory Board (SAB).

Professor Iwasaki is currently the Waldemar Von Zedwitz Professor in the Department of Immunology and a Professor in the Department of Molecular, Cellular and Developmental Biology at Yale University, where her team is studying immune responses to influenza in the lungs and the herpes simplex virus in the genital tract.

Ionis founder Stanley T Crooke to retire

Published on: 18/12/20

Ionis Pharmaceuticals has announced that its founder, Dr Stanley T Crooke, will retire from the company and its board of directors effective June 2021.

Sage Therapeutics appoints Barry Greene as CEO

Published on: 18/12/20

Sage Therapeutics, a biopharmaceutical company focused on developing treatments for central nervous system disorders, has appointed Barry Greene as Chief Executive Officer in a move to accelerate the company’s growth and leverage the talents of the leaders in the brain health space.

Top Ten most popular articles on this week

The top news stories of the past week continue to centre around the COVID-19 pandemic; a new variant of the virus has been identified in the UK, extra doses found in vials of the Pfizer vaccine have boosted the US’ supply, and researchers have said that a quarter of the global population may not be vaccinated until 2022.

Meanwhile, a number of treatments have secured recommendation or approval, including Janssen's esketamine nasal spray for patients with major depressive disorder, and Novartis' Beovu for wet age-related macular degeneration.

Samsung Biologics names John Rim as CEO and President

Published on: 17/12/20

Samsung Biologics has appointed John Rim as the company’s President and CEO. The appointment was made effective immediately and formalised via the company's board of directors meeting yesterday.

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches